Literature DB >> 894287

A sensitive enzymatic-radioisotopic assay for 3,4-dihydroxyphenylacetic acid.

J W Kebabian, J M Saavedra, J Axelrod.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 894287     DOI： 10.1111/j.1471-4159.1977.tb10630.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN： 0022-3042            Impact factor:   5.372


× No keyword cloud information.
  7 in total

1.  Effects of striatal lesions with kainic acid on morphine-induced "catatonia" and increase of striatal dopamine turnover.

Authors:  U Havemann; M Winkler; E Genç; K Kuschinsky
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-08       Impact factor: 3.000

2.  Influence of monoamine oxidase inhibition on the release of 3H-dopamine elicited by potassium and by amphetamine from the rat substantia nigra and corpus striatum.

Authors:  S Arbilla; S Z Langer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-02       Impact factor: 3.000

3.  A radioenzymatic method to measure picogram amounts of dopamine and 3,4-dihydroxyphenylacetic acid (DOPAC) in small samples of brain tissue.

Authors:  A Argiolas; F Fadda
Journal:  Experientia       Date:  1978-06-15

4.  Conjoint radioenzymatic measurement of catecholamines, their catechol metabolites and DOPA in biological samples.

Authors:  H M Thiede; W Kehr
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-12       Impact factor: 3.000

5.  Comparison of the effects of dopamine D1 and D2 receptor antagonists on rat striatal, limbic and nigral dopamine synthesis and utilisation.

Authors:  O Magnusson; B Mohringe; C J Fowler
Journal:  J Neural Transm       Date:  1987       Impact factor: 3.575

6.  Dopamine, noradrenaline and 3,4-dihydroxyphenylacetic acid (DOPAC) levels of individual brain nuclei, effects of haloperidol and pargyline.

Authors:  M I Fekete; J P Herman; B Kanyicska; M Palkovits
Journal:  J Neural Transm       Date:  1979       Impact factor: 3.575

7.  In vivo evidence for a concordant response of terminal and dendritic dopamine release during intranigral infusion of drugs.

Authors:  B H Westerink; M Santiago; J B De Vries
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-12       Impact factor: 3.000
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.